Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 2 | Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

Fig. 2

From: A randomized clinical trial of intranasal dexmedetomidine versus inhaled nitrous oxide for procedural sedation and analgesia in children

Fig. 2

Highest pain level during the procedure. Pain level was assessed with Face, Legs, Activity, Cry, Consolability scale (FLACC). This diagram shows the distribution of FLACC scores per drug. The median (IQR) of highest FLACC with patients receiving intranasal dexmedetomidine was 4 (3-6) and nitrous oxide 4 (2-6), p-value 0.41. The median of the difference between samples from each group for FLACC was 0 with 95%CI (0–1) which is within the predefined limit for non-inferiority

Back to article page